FibroBiologics (NASDAQ:FBLG) Given Buy Rating at HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of FibroBiologics (NASDAQ:FBLG) in a research report report published on Wednesday,Benzinga reports. HC Wainwright currently has a $12.00 price objective on the stock.

A number of other analysts have also issued reports on the stock. Maxim Group began coverage on shares of FibroBiologics in a research report on Tuesday, September 24th. They issued a “buy” rating and a $12.00 price target for the company. EF Hutton Acquisition Co. I raised shares of FibroBiologics to a “strong-buy” rating in a research report on Wednesday, September 4th.

FibroBiologics Price Performance

NASDAQ:FBLG opened at $3.06 on Wednesday. FibroBiologics has a 1-year low of $1.08 and a 1-year high of $55.00. The business’s fifty day moving average price is $2.97 and its 200 day moving average price is $5.00.

Hedge Funds Weigh In On FibroBiologics

Several large investors have recently added to or reduced their stakes in the company. Fund Evaluation Group LLC acquired a new position in shares of FibroBiologics in the second quarter valued at $5,265,000. Cascade Financial Partners LLC acquired a new stake in FibroBiologics in the 2nd quarter valued at $1,572,000. Transform Wealth LLC bought a new stake in shares of FibroBiologics in the 2nd quarter worth about $668,000. Bank of New York Mellon Corp acquired a new position in FibroBiologics in the second quarter valued at about $342,000. Finally, RMR Wealth Builders bought a new stake in FibroBiologics during the 2nd quarter worth approximately $186,000.

FibroBiologics Company Profile

FibroBiologics, Inc operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. It holds 150+ U.S. and internationally issued patents/patents pending across various clinical pathways, including disc degeneration, orthopedics, multiple sclerosis, psoriasis, wound healing, reversing organ involution, and cancer.